• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】31789

【品名】4,5-dimethoxy-2-nitrobenzoic acid

【CA登记号】4998-07-6

【 分 子 式 】C9H9NO6

【 分 子 量 】227.1736

【元素组成】C 47.58% H 3.99% N 6.17% O 42.26%

与该中间体有关的原料药合成路线共 7 条

合成路线1

该中间体在本合成路线中的序号:(I)

4,5-Dimethoxy-2-nitrobenzoic acid (I) was converted to the corresponding acid chloride (II) upon treatment with SOCl2, and this was further coupled to aniline (III), producing amide (IV). Catalytic hydrogenation of the nitro group of (IV) afforded amine (V). Acid chloride (VII) --obtained by chlorination of 3-quinolinecarboxylic acid (VI) with SOCl2-- was then condensed with amine (V) to furnish the title diamide.

2 Ryder, H.; Ashworth, P.A.; Roe, M.J.; Brumwell, J.E.; Hunjan, S.; Folkes, A.J.; Sanderson, J.T.; Williams, S.; Maximen, L.M. (Xenova Group plc); Anthranilic acid derivs. as multi drug resistance modulators. EP 0934276; GB 2334521; JP 2001502683; US 6218393; WO 9817648 .
1 Roe, M.; et al.; Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg Med Chem Lett 1999, 9, 4, 595.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 19194 4-[2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl]aniline; 4-[2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl]phenylamine C19H24N2O2 详情 详情
(IV) 59595 N-(4-{2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl}phenyl)-4,5-dimethoxy-2-nitrobenzamide C28H31N3O7 详情 详情
(V) 59596 2-amino-N-(4-{2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl}phenyl)-4,5-dimethoxybenzamide C28H33N3O5 详情 详情
(VI) 59597 3-Quinolinecarboxylic acid; Quinoline-3-carboxylic acid 6480-68-8 C10H7NO2 详情 详情
(VII) 59598 3-quinolinecarbonyl chloride C10H6ClNO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

4,5-Dimethoxy-2-nitrobenzoic acid (I) was treated with thionyl chloride to form acid chloride (II), followed by reaction with ammonia to yield 4,5-dimethoxy-2-nitrobenzamide (III). This was reduced with sodium borohydride in the presence of copper sulfate to give aminobenzamide (IV), which was refluxed with formic acid to afford 6,7-dimethoxyquinazoline-4(3H)-one (V). Subsequent treatment of (V) with phosphoryl chloride gave the chloroquinazoline (VI). The title compound was then prepared by condensation of (VI) with 2-bromo-4-aminophenol (VII) in refluxing ethanol.

1 Liu, X.-P.; Narla, R.K.; Uckun, F.M. (Parker Hughes Institute); Quinazolines for treating brain tumor. WO 9961428 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(IV) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(V) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(VI) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(VII) 31793 4-amino-2-bromophenol C6H6BrNO 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

4,5-Dimethoxy-2-nitrobenzoic acid (I) was treated with thionyl chloride to form acid chloride (II), followed by reaction with ammonia to yield 4,5-dimethoxy-2-nitrobenzamide (III). This was reduced with sodium borohydride in the presence of copper sulfate to give aminobenzamide (IV), which was refluxed with formic acid to afford 6,7-dimethoxyquinazoline-4(3H)-one (V). Subsequent treatment of (V) with phosphoryl chloride gave the chloroquinazoline (VI). The title compound was then prepared by condensation of (VI) with 4-aminophenol (VII) in refluxing ethanol.

1 Liu, X.-P.; Narla, R.K.; Uckun, F.M. (Parker Hughes Institute); Quinazolines for treating brain tumor. WO 9961428 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(IV) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(V) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(VI) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(VII) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Treatment of 4,5-dimethoxy-2-nitro benzoic acid (I) with H2SO4 in EtOH allows formation of the corresponding ethyl ester (II), the nitro group of which is then reduced by hydrogenation over Pd/C in EtOH to provide substituted aniline (III). Finally, the desired product is obtained by condensation of (III) with acid chloride (IV) in CH2Cl2 by means of Et3N (acid chloride (IV) can be obtained by treatment of the corresponding benzoic acid (V) with SOCl2 in refluxing chloroform).

1 Isobe, Y.; Misawa, S.; Hayashi, H.; Ogita, H.; Takaku, H.; Sekine, R.; Goto, Y.; Synthesis and structure-activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human coronary artery smooth muscle cells. Bioorg Med Chem Lett 2001, 11, 4, 549.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 50082 ethyl 4,5-dimethoxy-2-nitrobenzoate C11H13NO6 详情 详情
(III) 47630 ethyl 2-amino-4,5-dimethoxybenzoate C11H15NO4 详情 详情
(IV) 13571 3,4,5Ttrimethoxybenzoyl chloride 4521-61-3 C10H11ClO4 详情 详情
(V) 32225 3,4,5-trimethoxybenzoic acid 118-41-2 C10H12O5 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

Chlorination of 2-nitro-4,5-dimethoxybenzoic acid (I) by using oxalyl chloride and DMF provides acid chloride (II), which is subsequently coupled to hydroxyproline methyl ester (III) to yield amide (IV). Catalytic hydrogenation of the nitro group of (IV), followed by intramolecular cyclization leads to the tricyclic lactam (V). In order to protect the lactam NH of (V), the hydroxyl group is first converted into the silyl ether (VI), which is further treated with trimethylsilylethoxymethyl chloride and NaH to give the SEM-lactam (VII). Selective O desilylation of (VII) is accomplished by means of tetrabutylammonium fluoride, providing alcohol (VIII). Oxidation of (VIII) under Swern reaction conditions gives rise to ketone (IX).

1 Thurston, D.E.; Howard, P.W. (University of Portsmouth); Compounds. EP 1109812; WO 0012508 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 15796 methyl (2S,4R)-4-hydroxytetrahydro-1H-pyrrole-2-carboxylate C6H11NO3 详情 详情
(IV) 61271 methyl (2S,4R)-1-(4,5-dimethoxy-2-nitrobenzoyl)-4-hydroxy-2-pyrrolidinecarboxylate C15H18N2O8 详情 详情
(V) 61272 (2R,11aS)-2-hydroxy-7,8-dimethoxy-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione C14H16N2O5 详情 详情
(VI) 61273 (2R,11aS)-2-{[tert-butyl(dimethyl)silyl]oxy}-7,8-dimethoxy-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione C20H30N2O5Si 详情 详情
(VII) 61274 (2R,11aS)-2-{[tert-butyl(dimethyl)silyl]oxy}-7,8-dimethoxy-10-{[2-(trimethylsilyl)ethoxy]methyl}-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione C26H44N2O6Si2 详情 详情
(VIII) 61275 (2R,11aS)-2-hydroxy-7,8-dimethoxy-10-{[2-(trimethylsilyl)ethoxy]methyl}-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione C20H30N2O6Si 详情 详情
(IX) 61276 (11aS)-7,8-dimethoxy-10-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2,5,11(3H,10H,11aH)-trione C20H28N2O6Si 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

 

1 Zhu CQ, Chi YS, Deng, YL,et aL 2006.Process for preparation of 4-(3’-chloro-4'-fluoroanilino)-7-methoxy6-(3-morpholinopropoxy) quinazoline.发明专利申请公开说明书,CN 1733738
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13439 3,4-Dimethoxybenzoic acid 93-07-2 C9H10O4 详情 详情
(II) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(III) 66449 2-amino-5-hydroxy-4-methoxybenzoic acid   C8H9NO4 详情 详情
(IV) 66450 6-hydroxy-7-methoxyquinazolin-4(1H)-one   C9H8N2O3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(X)

Chlorination of 4,5-dimethoxy-2-nitrobenzoic acid (X) with SOCl2, followed by reaction with aqueous ammonia yields the nitrobenzamide (XI), which is reduced to the corresponding aminobenzamide (XII) by means of NaBH4 in the presence of catalytic amounts of CuSO4. Anthranilamide (XII) is then cyclized to quinazolinone (XIII) by refluxing in formic acid . Alternatively, cyclization of 4,5-dimethoxyanthranilic acid (XIV), either by heating with formamide at 190 °C or with formamidine hydrochloride at 210 °C , gives rise to quinazolinone (XIII) . Subsequent chlorination of compound (XIII) to the corresponding 4-chloroquinazoline (XV) is accomplished by treatment with either POCl3 , SOCl2 or (COCl)2 in the presence of catalytic amounts of DMF. Chloroquinazoline (XV) is then condensed with 3-bromoaniline (VIII) in refluxing EtOH or i-PrOH to produce anilinoquinazoline (XVI) , which is finally demethylated by either treatment with BBr3 in THF or by heating with pyridinium chloride at 205 °C .

1 Hu, S., Xie, G., Zhang, D.X. et al. Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorg Med Chem Lett 2012, 22(19): 6301-5.
2 Uckun, F.M., Narla, R.K., Liu, X.-P. (Parker Hughes Institute). Quinazolines for treating brain tumor. EP 1082311, JP 2002516823, US 6316454, WO 1999061428.
3 Barker, A.J. (AstraZeneca plc). Quinazoline derivatives. CA 2086968, EP 0566226, JP 1994073025, US 5457105, US 5616582.
4 Johnström, P., Fredriksson, A., Thorell, J.-O., Stone-Elander, S. Synthesis of [methoxy-11C]PD153035, a selective EGR receptor tyrosine kinase inhibitor. J Label Compd Radiopharm 1998, 41(7): 623-9.
5 Bridges, A.J., Zhou, H., Cody, D.R. et al. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem 1996, 39(1): 267-76.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 67978 4-[(3-bromophenyl)amino]-6,7-dihydroxyquinazoline   C14H10BrN3O2 详情 详情
(VIII) 19136 3-bromoaniline; 3-bromophenylamine; 3-bromobenzenamine 591-19-5 C6H6BrN 详情 详情
(X) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(XI) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(XII) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(XIII) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(XIV) 23763 2-amino-4,5-dimethoxybenzoic acid 5653-40-7 C9H11NO4 详情 详情
(XV) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(XVI) 67984 N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride 183322-45-4 C16H14BrN3O2.HCl 详情 详情
Extended Information